Research Article: Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives
Abstract:
In diabetic metabolic disorders, advanced glycation end products (AGEs) contribute significantly to the development of cardiovascular diseases (CVD).
Introduction:
Diabetic metabolic disorders are a heterogeneous group of conditions characterized by chronic hyperglycemia resulting from defects in insulin secretion, action, or both, and are associated with a wide range of complications, including microvascular and macrovascular diseases [1]. Cardiovascular disease (CVD) represents a major cause of morbidity and mortality in patients with diabetes, accounting for approximately 50% of all diabetes-related deaths [2]. Hence, understanding the pathophysiological mechanisms…
Read more